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Summary 
 
Testicular tissue is extremely sensitive to external stress such as cancer 
treatments, which induce inappropriate germ cell apoptosis leading to 
defects in reproductive health (1, 2). For postpubertal men, 
cryopreservation of sperm or testicular tissue is a proven method for 
preserving fertility against the effects of these treatments (3). 
Unfortunately, no such method exists for prepubertal boys, whose 
spermatogenesis has not yet begun (3). For these boys, the best way to 
preserve fertility would be to protect the spermatogenic stem cells against 
apoptosis induced by cancer treatments in vivo. 
 
Strategies aimed at cell protection should be directed at inhibiting the 
early signals in apoptosis cascades (4). Sphingolipids are powerful 
mediators of diverse cellular processes, such as apoptosis and cellular 
differentiation, and thus hold great promise in different fields of cancer 
research (5). The sphingolipid metabolites ceramide and sphingosine-1-
phosphate (S1P) represent early mediators of apoptosis (6). Ceramide 
plays an important role in the induction of apoptosis, whereas S1P is 
considered to be a survival factor. S1P was recently demonstrated to block 
mouse oocyte apoptosis induced by cancer therapies in vitro and in vivo 
(7), suggesting that modulation of the sphinoglipid pathway is a 
reasonable attempt to protect germ cells from unwanted cell death. Little, 
however, is known of how S1P exerts its antiapoptotic effects. Initially, 
S1P was suggested to act as an intracellular signaling molecule and the 
balance between the intracellular levels of S1P and ceramide to be crucial 
in determining whether the cell will survive or die. The issue is, however, 
complicated by the latest findings that S1P not only acts as an intracellular 
second messenger but also as a ligand to its receptors, recently renamed 
as S1P1, S1P2, S1P3, S1P4, and S1P5. 
 
In the present study, we aimed at evaluating the inhibitory potential of 
S1P against male germ cell apoptosis induced by external stress in vitro 
and in vivo and at characterizing the mechanisms, by which S1P inhibits 
this apoptosis. The in vitro studies, in which culture of human 
seminiferous tubules was used as a model for external stress situations, 
showed that during male germ cell apoptosis testicular ceramide levels 
increase rapidly before initiation of caspase 3 activation and apoptotic 
DNA fragmentation and that in cultured human seminiferous tubules, 
germ cell death can be inhibited by exogenous S1P. Consistent with 
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previous findings in the rodent testis, we detected expression of the S1P1 
and S1P2 receptors in somatic Sertoli cells. S1P, however, appears to 
inhibit male germ cell apoptosis of the human testis independently of its 
receptors. We demonstrated that intracellularly generated S1P inhibits 
transcription factor nuclear factor κB (NF-κB), which in turn is regulated 
upstream by Akt. The transcription factor activator protein 1 (AP-1), which 
regulates diverse cellular pathways including apoptosis, and is suggested 
to play a role in the regulation of spermatogenesis, appears to play no role 
in S1P-related inhibition of male germ cell death. 
 
The potential ability of S1P to protect male germ cells against irradiation-
induced cell death in an animal model was also investigated in vivo. In 
mice, irradiation mainly damaged the early developmental stages of 
spermatogonia. After 21 d, testes treated with S1P before irradiation 
showed modest preservation of early spermatogonia, as detected by DNA 
flow cytometric analysis of 4C population of spermatocytes: the number of 
these cells was reduced in irradiated, but not in irradiated plus S1P-
protected testes. 
 
The present results show that apoptosis of male germ cells involves 
sphingolipids and can be partially inhibited by S1P. Our findings are 
important in understanding the mechanism of germ cell death and in 
attempts to find ways to prevent its inappropriate occurrence, although 
much work needs to be done before S1P can be considered as a potential 
therapeutic agent against male germ cell apoptosis. By manipulating the 
enzymes that regulate the intracellular sphingolipid rheostat, the 
intracellular level of S1P may be adjusted to the level needed for optimal 
inhibition of unwanted male germ cell apoptosis caused by external stress. 
Alternatively, other as yet unknown compounds, possibly in the 
sphingolipid pathway, may prove to be more effective than S1P. 
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Abbreviations 
 
Apaf-1   Apoptotic protease-activating factor 1 
ASMase  Acid sphingomyelinase 
ASMKO  Acid sphingomyelinase knockout 
AP-1   Activator protein 1 
cAMP   cyclic adenosine monophosphate 
DMS   N,N dimethylsphingosine 
Cyt-c   Cytochrome c 
dS1P   Dihydrosphingosine-1-phosphate 
EDG   Endothelial differentation gene 
EMSA   Electron mobility shift assay 
ERK   Extracellular signal-regulated kinase 
E2   17β estradiol 
FasL   Fas ligand 
FB 1   Fumonisin B1 
FSH   Follicle-stimulating Hormone 
GnRH   Gonadotropin-stimulating Hormone 
Gy   Gray 
ICSI   Intracytoplasmic sperm injection 
Iκβ   Inhibitory κB 
Iκβα   Inhibitory κBα 
IKK   Inhibitory kappa kinase 
ISEL   In situ end labeling 
JNK   c-Jun terminal kinase 
KCN   Potassium cyanide 
KO   Knockout  
MAP   Mitogen-activated protein 
MAPK   Mitogen-activated protein kinase 
NAC   n-acetyl-L-kysteine 
NF-κB   Nuclear Factor κB 
NSMASE  Neutral sphingomyelinase 
PI3   Phosphatidyl inositol 
PI3K   Phosphatidyl inositol kinase 
PBS   Phosphate buffered saline 
PT   Permeability transition 
ROS   Reactive oxygen species 
S1P   Sphingosine-1-phosphate 
S1PR   Sphingosine-1-phosphate receptor 
SM   Sphingomyelin 
Smase   Sphingomyelinase 
SPHK   Sphingosine kinase 
TNF   Tumor necrosis factor 
WT   Wild type 
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Review of the literature 
 
 
Introduction 
 
Childhood cancer treatments 
 
With advancement in cancer treatments the overall survival rate in most 
childhood cancers is almost 85% (1). In boys destruction of the 
spermatogonial stem cells in the testis is a severe side effect of 
chemotherapy and radiation. These treatments may lead to failure of 
spermatozoa formation after puberty and consequent infertility in adulthood 
(1), which is physiologically one of the most traumatic late complications 
among long-term survivors and one of the major factors decreasing their 
quality of life (8). Fertility in adult men can be restored by cryopreservation of 
spermatozoa before cancer treatments (1, 3). Prepubertal boys, 
unfortunately, cannot benefit from this option, due to the absence of haploid 
gametes (1, 3). In men preservation of fertility may also be achieved by germ 
cell transplantation or by in vitro maturation (1-3). Alternatively, rendering 
the testis tissue quiescent during cytotoxic treatments may protect the germ 
cells from subsequent damage (1, 2). Despite many attempts, however, 
these methods have not yet benefited prepubertal boys (1-3). 
 
Since most cancer treatments aim at induction of apoptosis in cancer cells (9, 
10), modulation of the apoptotic response by manipulating specific apoptotic 
signaling pathways may prove useful in attempts to protect normal cells 
against the side effects of these treatments (9). A body of evidence indicates 
that certain therapeutic approaches that regulate cell membrane-bound 
sphingomyelin (SM) metabolism or endogenous concentrations of its 
metabolites may be one such alternative (5). Promising results were obtained 
in female mice, in which oocytes were protected against irradiation-induced 
ovarian failure by means of sphingosine-1-phosphate (S1P) given before 
irradiation (7). The use of S1P in male germ cell preservation, however, 
remains unknown. 
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Germ cells in testes of prepubertal boys 
 
Although the prepubertal testis does not complete spermatogenesis and 
produce mature spermatozoa, it displays significant cellular activity essential 
for normal adult function (11, 12). The testis triples its volume between birth 
and the onset of puberty (13). The seminiferous epithelium of normal infant 
and child testes generally consists of immature Sertoli cells and different 
types of spermatogonia (14). These spermatogonia proliferate by mitosis but 
do not enter meiosis. This increase in spermatogonial number is essential for 
the achievement of quantitatively normal sperm production in adult life (15). 
Although the prepubertal testis consists of some spermatocytes and 
spermatids and isolated phases of spermatogonial proliferation followed by 
the transient appearance of primary meiotic spermatocytes and spermatids 
exist, such germ cells degenerate and fail to develop into spermatozoa (11, 
15).  
 
Effect of anti cancer treatments on spermatogenesis 
 
Gonadal damage in prepubertal boys may result from systemic chemotherapy 
or radiotherapy involving the spinal or pelvic area. These treatments lead to 
destruction of the spermatogonial stem cells, involving also the somatic 
Sertoli- and Leydig cells, although these cells are rather resistant to 
gonadotoxic therapy (16-18). Androgen production may therefore be restored 
and secondary sexual characteristics of these boys develop normally even 
when patients are infertile. Cancer treatments may also lead to the Sertoli cell 
only syndrome that represents the seminiferous tubules, in which the germ 
cells are completely absent (19). 
 
Cytotoxic treatments target rapidly dividing cells and are therefore especially 
damaging to the differentiating spermatogonia and stem cells (2, 16). The 
degree of injury on the spermatogenic epithelium is dependent on the type, 
combination, and dosage of the chemotherapy received (18). Drugs known to 
cause germ cell damage include procarbazine, vinblastine, cytosine 
arabinoside, and the alkylating agents, particularly cyclophosphamide, 
chlorambucil, mechlorectamine, and the nitrosureas (18). 
 
REVIEW OF THE LITERATURE
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In prepubertal cancer patients, radiation-induced gonadal damage is most
often observed following direct testicular irradiation for treatment of
testicular relapse of leukemia, or following total body irradiation given
prior to bone marrow transplantation (2). The most sensitive germ cells
are the spermatogonia; doses of radiation as low as 0.1 Gy are known to
cause damage to these cells (20-22). Doses of radiation from 0.1 to 0.3
Gy cause temporary oligospermia, and after 0.3-2.0-Gy, the recovery
requires as long as 30 months. Recovery generally occurs, if the doses
remain under 1-2 Gy; doses exceeding 2-3 Gy, however, induce
irreversible germinal damage accompanied by increased levels of follicle–
stimulating hormone (FSH) and decrease in testicular volume (18, 23).
Somatic cells are more resistant to radiation therapy than germ cells,
Leydig cell function is usually preserved following doses as high as 12 Gy
(2).
Options for fertility preservation
Cryopreservation of testicular spermatozoa
Cryopreservation of spermatozoa is commonly used in preservation of
fertility for adult cancer patients (1-3), while advances in techniques of
assisted reproduction, especially intracytoplasmic sperm injection (ICSI),
have enabled men with oligospermia to become fathers (3, 8).
Unfortunately, no equivalent method is available for prepubertal boys with
absence of haploid gametes (1-3). 
Cryopreservation of testicular tissue
Testicular tissue from men was successfully cryopreserved as cell
suspensions (24) or as pieces of tissue (25). Healthy offspring were born
as a result of ICSI carried out using spermatozoa after both freezing
methods (3). To maintain the reproductive capacity of prepubertal boys,
the aim would be to cryopreserve the spermatogonia (3), which are large
cells and located in the basal part of the seminiferous epithelium. Since
human testicular tissue is relatively dense, its dispersion in cell
suspensions is unknown (3). In theory, spermatogonia could be harvested
from a biopsy and stored prior to cancer therapy, either as a segment of
tissue or isolated germ cells (3). After the original disease has been cured,
reimplantation of frozen thawed testicular cells back to the seminiferous
tubules could be one method of initiating spermatogenesis (3). This
method is possible in rodents, and attempts at injecting frozen thawed cell
suspensions were carried out in human adult
REVIEW OF THE LITERATURE 
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males (3). In the rat model, however, injection of as few as 20 leukemic cells 
mixed with germ cells was able to cause leukemia in the recipient (26). Thus, 
if a boy has a hematological malignancy, high risk ensues of transplanting 
cancer cells back to him after the cure (3). For such boys, maturation of 
spermatozoa in vitro may be a better option. Clinically, however, the low 
number of spermatogonia makes this option extremely difficult to carry out 
succesfully.  
 
In vitro maturation 
Maturing frozen thawed spermatogonia in vitro aims at stimulating their 
differentation into spermatozoa under culture conditions (3). In mice, 
spermatogonial stem cells survive for up to four months in culture, retaining 
the ability to initiate spermatogenesis following transplantation back into a 
recipient (27). Complete spermatogenesis in vitro seems nevertheless a 
remote possibility, since it has not yet been successfully demontrated in any 
animal species (3).  
 
Germ cell transplantation 
The technique of spermatogonial stem-cell transplantation was introduced in 
1994 (28). Injection of germ cell suspensions from donor mice into 
genetically sterile mice resulted in restoration of spermatogenesis from the 
donor stem cells (28). Similar results were demonstrated in recipient mice 
that received sterilizing treatment with busulfan (28). In addition, successful 
transfer of germ cells between species was demonstrated, with restoration of 
rat spermatogenesis following transplantation of rat germ cells into the 
seminiferous tubules of mice (29). Possibly due to presence of inappropriate 
microenvironments for the proliferation of donor spermatogonia, germ cell 
transplantation between phylogenetically more distant species, such as from 
rabbits and dogs into mice, has not been successful (30). Successful 
spermatogenesis, however, was achieved following xeno grafting of testicular 
tissue from mice, pigs, and goats into castrated, immunodeficient mice (31). 
Although the risk of reintroducing malignant cells would be eliminated, the 
clinical application of germ cell transplantation carries a high risk of inter 
species transfer of potentially pathogenic micro organisms (2). 
 
Pharmacological protection of testicular tissue  
The hypothesis that prepubertal boys have low rates of permanent 
chemotherapy-induced gonadal damage has led many investigators to believe 
REVIEW OF THE LITERATURE 
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that suppression of testicular function at the prepubertal level may provide 
protection against cytotoxic therapy (32). Although in humans no evidence 
for this exists, promising results were achieved in animal studies (33). 
Recovery of spermatogenesis with hormone treatments was demonstrated in 
procarbazine-treated rats by administration of the gonadotropin-releasing 
hormone (GnRH) analogue Zoladex for two weeks prior to and during 
chemotherapy (34). Similar effects were described following the use of 
testosterone (35), testosterone and estradiol (36), and GnRH antagonist 
combined with testosterone (37) following gonadal insult with chemotheraphy 
or irradiation. Although these hormone treatments showed promising results 
in rats even when given after irradiation (38), clinical trials of hormonal 
manipulation in patients receiving gonadotoxic therapy failed to demonstrate 
any advantage (2).  
 
Amifostine, an organic triphosphate that acts through free-radical scavenging, 
hydrogen donation, and inhibition of DNA damage (39) is one 
pharmacological compound that shows selective protection in many human 
tissues against the toxic side effects of radiation and cytotoxic drugs, while 
preserving the antitumor efficacy of the treatment (39). Reports of its effect 
on testicular tissue, however, are conflicting (40, 41) and, most importantly, 
knowledge of its usefulness in children is scarce (40).  
 
Use and design of less toxic chemotherapeutic drugs and refined radiation 
techniques with less toxic long-term effects will hopefully become one future 
option for decreasing testicular damage (18). 
 
Cancer treatments and apoptosis 
Several cancer treatments aim at eradicating tumor cells by apoptosis (9, 42, 
see next chapter). Defects in apoptotic machinery or stimulation of survival 
pathways, however, may prevent the cells from responding to apoptotic 
stimuli (9). Modulation of the apoptotic response by manipulating specific 
apoptotic signaling pathways, therefore, may enhance the therapeutic ratios 
of cancer treatments (9). More importantly, such manipulation may also be 
useful in attempts to protect normal cells against unwanted apoptosis 
induced by cancer treatments (9). A growing body of evidence indicates that 
certain therapeutic approaches that regulate cell membrane-bound SM 
metabolism or endogenous concentrations of its metabolites may be useful in 
attempts to manipulate the apoptotic machinery induced by cancer 
REVIEW OF THE LITERATURE 
_____________________________________________________________ 
 15
treatments (5). Proapoptotic ceramide and antiapoptotic S1P are metabolites 
of SM and represent early mediators of apoptosis (6). Promising results have 
been obtained in female mice oocytes, in which radiation-induced premature 
ovarian failure could be prevented by protecting the ovaries with S1P before 
irradiation. The S1P-treated ovaries retained a normal distribution of follicles 
as well as overall tissue mass (7). No genetic anomalies in the progeny of 
irradiated mothers were found (43). Sphingolipid-based therapeutics are 
currently being under preclinical and clinical investigation, and S1P represents 
the first agent capable of protecting female germ cells against exposure to 
irradiation (5). The potential ability of S1P to protect germ cells from 
apoptosis in the testis, however, remains unknown. 
 
 
 
Apoptosis 
 
Apoptosis, also known as programmed cell death, is a regulatory mechanism 
that eliminates abundant and unwanted cells in an organized fashion during 
embryonic development, growth, differentation and normal cell turnover (44). 
The morphological features of apoptosis include condensation of nuclear 
cromatin, blebbing of the cellular membrane, shrinkage of the cell, and 
fragmentation of the cell including its nucleus into small apoptotic bodies that 
are engulfed in vivo by macrophages or other cells of the mononuclear 
phagocyte system (45). A normal degree of apoptosis is important for 
adequate development of organisms and maintenance of homeostasis, 
whereas excessive or inadequate levels of apoptosis are associated with 
disease processes and are critical factors in the pathogenesis of a number of 
diseases (45). The capability for specifically manipulating cell death, i.e. 
increasing or decreasing its occurrence, thus holds great promise for the 
future development of therapies (46).  
 
Apoptotic cell death machinery consists of a complex network of tightly 
controlled signaling pathways (Fig. 1). Which apoptotic signal the cell death 
machinery conducts is dependent on the death-inducing stimululus, the 
surrounding environment, and the type of cell (47).  
REVIEW OF THE LITERATURE 
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Apoptotic pathways in general 
 
Caspases  
The caspases are a family of cysteine proteases that are able to cleave their 
substrates, transforming procaspase into active caspase (47-50). They can be 
roughly divided into initiator and effector caspases (51). The initiator 
caspases (caspases 2, 8, 9, and 10) interact with various caspase-activating 
proteins. After activation, they cleave the effector caspases (caspases 3, 6, 
and 7) that amplify the apoptotic signal by cleaving the substrates 
responsible for the morphological changes characteristic of apoptotic cell 
death (52). Caspases can be activated via the mitochondrial or death 
receptor pathways. Whatever the pathway, the final results are specific and 
the uniform morphologic features of apoptosis consistent in different tissues 
and organisms (48-50). 
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Figure 1. Schematic illustration demonstrating the cell death machinery. The death receptor 
pathway can be triggered by members of the death receptor superfamily, such as Fas and 
TNFR1. Activation of the death receptors is followed by recruitment of several adapter 
proteins and consequent activation of procaspase 8. In the mitochondria-independent 
pathway, active caspase 8 directly activates effector caspases, such as caspase 3 and 7. In 
the mitochondria-dependent pathway, caspase 8 cleaves proapoptotic Bid, which 
translocates to the mitochondria. The truncated Bid, together with other proapoptotic Bcl-
family proteins, such as Bax, participates in mitochondrial events, such as membrane 
permeability transition (PT) and release of cytochrome c (cyt-c). The anti-apoptotic Bcl-
family members (Such as Bcl-2 and Bcl- XL) counteracts these events. Various caspase-
independent stimuli can also induce the mitochondrial events and the release of cyt-c, 
apoptosis-inducing factor (AIF), Smack/DIABLO (second mitochondria-derived activator of 
caspases/direct IAP-binding protein with a low isoelectric point), and several other 
apoptosis-inducing factors. Reactive oxygen species (ROS), formed in the mitochondria 
during apoptosis, are able to regulate the cell death machinery at several levels. Cyt-c, 
released from the mitochonria, associates with caspase adaptor Apaf-1 and procaspase 9 to 
form the apoptosome. Smack/DIABLO antagonizes procaspase 3 by binding to and inhibiting 
the inhibitor of apoptosis proteins (IAPs).  
 
  
Death receptor pathway 
 
Apoptosis can be induced by ligation of a subset of plasma membrane tumor 
necrosis factor receptor (TNFR) family members, referred to as death 
receptors (53, 54). After binding of specific death ligands, they can activate 
caspases within seconds and cause apoptotic cell death within hours (53, 54). 
The best characterized subset of the death receptors are Fas (CD95/Apo-1) 
and TNFR1 (p55/CD120a) (53, 54). The ligands that bind to the death 
receptors, including FasL (CD95L) and TNFα, are structurally related proteins 
that belong to the TNF subfamily (53, 54). After ligation, the resulting 
complex recruits several molecules of procaspase 8, resulting in autocatalytic 
liberation of active caspase 8, which is considered to be the key initiator 
caspase in the death receptor pathway (47). After this point, active caspase 8 
may activate other caspases or death messengers, mediating the apoptosis 
signal via separate pathways depending on the cell and stimulus (47).  
 
Mitochondrial pathway 
 
The mitochondria are important regulators of oxidative conditions and the 
main cellular source of reactive oxygen species (ROS) (55, 56). Diverse 
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apoptotic pathways converge toward the mitochondria and trigger 
permeability transition (PT) both in the inner and outer mitochondrial 
membranes (55, 57, 58). The Bcl-2 family members play an important role in 
mitochondrial apoptotic signaling pathways. The apoptotic stimuli cause a 
disequilibrium between the pro- and antiapoptotic family members that are 
located in the outer membrane of mitochondria or in the cytosol. 
Translocation of proapoptotic family members to the mitochondrial outer 
membrane leads to the release of cyt-c (or other mitochondrial proapoptotic 
factors) (57, 59-61). After accumulation in the cytoplasm, cyt-c binds to and 
oligomerizes apoptotic protease activating factor (Apaf-1) (55, 57, 58). 
Procaspase 9 then binds to Apaf-1 resulting in a formation of apoptosome, 
which is a high-molecular-mass complex that contains cyt-c, Apaf-1, and 
procaspase 9 (55, 57, 58). The interaction of procaspase 9 and Apaf-1 leads 
to formation of active caspase 9, which in turn proteolytically activates 
caspase 3 (57, 59, 60).  
 
Caspase-independent apoptosis 
 
Although caspase 3 is the primary effector caspase in most apoptotic 
cascades, caspase 3-independent and even caspase-independent cell deaths 
have been described (4, 62, 63) For example, apoptosis can be induced by 
overexpression of Bax (a proapoptotic Bcl-2 family member), even when the 
activity of caspases is blocked. This apoptosis is apparently due to 
mitochondrial energy depletion and generation of ROS (4, 47). Indeed, a 
variety of noncaspase proteases may induce apoptosis by triggering the 
mitochondrial pathway (47). For example, apoptosis-inducing factor (AIF) and 
endonuclease G may be released from mitochondria in either a caspase-
independent or -dependent manner and be translocated to the nucleus 
resulting in chromatin condensation (64). 
 
Activator protein 1 
 
Activator protein 1 (AP-1) is a transcription factor involved in a broad range 
of biological responses such as proliferation, transformation, cell 
differentiation, cell migration, and apoptosis (65-67). AP-1 activity can be 
induced by multiple environmental insults and physiological stimuli that 
activate mitogen-activated protein kinase (MAPK) cascades (65, 67). Three 
well-characterized subfamilies of MAPKs are present in multicellular 
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organisms: the extracellular signal-regulated kinase (ERK 1/2), the stress-
activated c-Jun aminoterminal kinases (JNKs), and the p38 enzymes (65, 67).  
 
AP-1 comprises a family of transcription factors including Jun and Fos 
subfamilies (68). After dimerization, these subunits bind to a common AP-1 
DNA-binding site where they regulate different target genes and thus execute 
diverse and distinct biological functions (65). AP-1 activation during apoptosis 
appears to be highly regulated in tissue -and developmental stage-specific 
manner (69-73). Although its activation enhances cell survival and 
proliferation, it also contributes to induction of apoptosis, especially under 
extreme conditions (65-68).  
 
 
Nuclear factor kappa B  
 
Nuclear factor kappa B (NF-κB) transcription factor proteins regulate genes 
that are involved in apoptosis, proliferation, migration, and stress, 
inflammatory, and immune responses (74-76). Prior to activation, NF-κB 
proteins are sequestered into the cytosol by inhibitory kappa B (IκB) proteins 
that release NF-κB after degradation, allowing its translocation into the 
nucleus (77). The degradation of IκB is controlled by the IκB kinase (IKK) 
complex, which in turn is regulated by several mechanisms, including the 
phosphatidyl inositol (PI3)/Akt kinase cascade (78).  
 
NF-κB transcription factors play pivotal roles in the regulation of pro and 
antiapoptotic pathways, depending on the inducing agent and cell type (79, 
80). NF-κB is usually cytoprotective and its inhibitory effect was observed in 
certain cells in response to certain external stimuli, such as TNF, ionizing 
radiation, and chemotherapeutic compounds (79, 80). A growing body of 
evidence, however, indicates the presence apoptosis-inducing functions in 
NF-κB (81-83). NF-κB-related control of apoptosis is important in normal 
processes, such as liver development, immune balance and homeostasis, as 
well as in pathological conditions such as cancer, and neurodegenerative 
diseases (79, 80). Therefore, agents that affect the ability of NF-κB to control 
apoptosis are likely to be clinically relevant (84). 
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Phosphatidyl inositol kinase 
 
The PI3 kinases are a family of lipid kinases that are involved in cell survival 
and proliferation in several cell types. An important result of PI3 
phosphorylation is activation and relocalization of cytoplasmic Akt (also 
known as PKB) at the plasma membrane (78, 85-87). The PI3/Akt kinase 
cascade regulates multiple cellular processes such as transcription, 
proliferation, angiogenesis, motility, survival, and apoptosis (78). Akt 
regulates apoptosis at multiple sites by directly phosphorylating components 
of the cell death machinery or by indirectly changing the levels of expression 
of genes that codes for the components of cell death machinery (78). The 
PI3/Akt kinase cascade is able to regulate NF-κB activity by regulating IKK 
(78, 88).  
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The sphingolipid pathway  
 
 
Sphingolipids are ubiquitous components of eukaryotic cell membranes, 
which by regulating apoptosis act as rheorstats that determine the fate of the 
cell (89). SM, located in the outer layer of the plasma membrane, comprises 
more than half of all plasma membrane-bound phospholipids. A variety of 
stimuli can induce enzymatic cleavage of SM, resulting in the release of 
bioactive messenger molecules that influence proliferation, differentation, and 
survival of various cell types (Fig. 2) (90-92).  
 
 
 
 
 
 
 
Figure 2.  Sphingolipid metabolism 
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Ceramide  
 
Ceramide acts as a ubiquitous second messenger in a number of evolutionary 
conserved signaling systems that regulate diverse cellular processes including 
apoptosis, the cell cycle, and cellular differentiation (93). It is a main 
metabolite of SM and can be formed from SM by sphingomyelinases (SMases) 
or de novo by the enzyme ceramide synthetase. Whatever ceramide pathway 
is activated, is highly dependent on the cell and stimulus (94). SMases that 
hydrolyze SM rapidly are classified into two main groups according to the pH 
optimum. Acid sphingomyelinase (ASMase) is a lysosomal enzyme that 
displays a pH optimum of 4.5 (92). Deficiency of ASMase causes Niemann-
Pick disease in humans (95). Several reports provided evidence that ASMase 
is the main enzyme for generating ceramide and mediating cell differentiation 
and apoptosis (96-98). Neutral sphingomyelinase (NSMase), with a neutral 
pH optimum has an association different from that of ASMase in the plasma 
membranes. Two different forms of NSMase are known: a membrane-
associated Mg 2+-dependent and a cytosolic Mg 2+-independent NSMase 
(92). Activation of NSMase may be modulated by the cellular redox state, 
with glutathione being a prominent negative regulator of NSMase activity 
(99). NSMase-related ceramide formation plays an important role in induction 
of apoptosis in many cell types (100).   
 
Alternatively, ceramide can be synthesized at the initial step of the SM 
signaling pathway by enhanced de novo synthesis from sphingosine or 
palmitoyl-CoA and serine by the enzyme ceramide synthetase (92). This 
pathway can be stimulated by drugs and ionizing radiation and it usually 
results in a prolonged ceramide elevation (91). Indeed, several anticancer 
agents act by increasing tumor cell ceramide via this pathway (91). 
 
Increased ceramide levels and exogenously added cell-permeable ceramide 
analogs induce apoptosis in several cell lines (101, 102). A wide range of 
inducing agents, which are considered cytotoxic or stressful, accumulate 
ceramide in the cell. These agents include TNFα, Fas ligation, interleukin-1, 
serum deprivation, heat shock, ischemia, ultraviolet light, radiation, and 
chemotherapeutic agents such as cytosine arabinoside, vincristine, and 
daunorubicin (91, 93, 103). Ceramide regulates apotosis via multiple signaling 
pathways and activates a number of enzymes involved in stress signaling 
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cascades (93). In mitochondria, it is able to form large stable pores in 
mitochondrial membranes, allowing cyt-c to be released in the cytosol (104). 
In addition, it may influence mitochondrial apoptosis signaling via the 
proapoptotic Bcl-2 family and generation of ROS (105). Whether it acts 
upstream or downstream caspases, remains unclear (106). Ceramide can be 
converted back to SM by SM synthase or alternatively into a variety of 
metabolites including glucosylceramides, ceramide-1-phosphate, sphingosine 
and S1P (91).  
 
Sphingosine 
 
Sphingosine is degraded from ceramide by ceramidase (107). It´s functions 
in the cell are controversial, depending on the enzyme activities, it may act as 
an inductor of apoptosis and negative regulator of cell proliferation or as a 
mitogen (92). The level of sphingosine in the cell is extremely low, since the 
entzyme sphingosine kinase (SPHK) is able to rapidly phosphorylyze 
sphingosine into S1P and thus catalyze its mitogenic functions (92, 107). 
Dephosphorylation of S1P back into sphingosine by S1P phosphatase, in turn, 
potentiates apoptosis (92). Which molecule will finally predominate and 
initiate the cell response is dependent of the rapid interconversion of the lipid 
molecules ceramide, sphingosine and S1P, which vary depending on the 
expression pattern of the cell and activity of the converting enzymes (92, 
107).  
 
Sphingosine kinase 
 
SPHK is predominantly a cytosolic enzyme and critical regulator of the 
sphingolipid rheostat (108). SPHK is encoded by a highly conserved gene 
family (109) and is activated by numerous external stimuli, in which growth 
and survival factors are the most prominent (110). Increase in SPHK activity 
leads to increased level of intracellular S1P, with concomitant decrease in the 
level of sphingosine and, to a lesser extent, ceramide (111, 112). SPHK and 
its activation, therefore, play a central role in controlling the cellular effects of 
S1P. 
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Sphingosine-1-phosphate 
 
S1P potentiates cell survival and inhibits apoptosis in several cell types (89, 
113-115). Initially, S1P was proposed to act as a direct intracellular second 
messenger, and the balance between S1P and its antagonist ceramide to 
determine whether the cell will survive or undergo apoptosis (116). More 
recently, the extracellular first messenger effects of S1P have been 
discovered; it acts as a ligand for a family of G-protein-coupled receptors that 
are expressed widely and differentially in several tissues (117). Depending on 
the abundance of S1P receptors (S1PR) and associated G-proteins, S1P is 
able to activate and regulate diverse signal transduction pathways in different 
cell types (110).  
 
S1P as a direct intracellular second messenger 
 
A variety of growth factors and cytokines activate SPHK thereby increasing 
the intracellular levels of S1P (115). This intracellularly generated S1P acts as 
a second messenger in cellular proliferation and survival as well as in 
protection against ceramide-mediated apoptosis (116, 118-121). The basal 
cellular level of S1P is low (115, 122) and tightly regulated by the balance 
between synthesis and degradation (115, 122). The inhibitory effect of S1P 
against ceramide-mediated cell death was originally proposed to be due to 
intracellularly generated S1P (116), supported by findings that the effects of 
S1P on ERK and JNK (116), and on caspases (118) are opposed by elevated 
levels of intracellular ceramide. Secondly, dihydroS1P (dS1P), an analog of 
S1P that binds to S1PRs but does not act as an intracellular second 
messenger, is not able to mimic all of the effects of S1P, especially those 
related to cell survival (119). For example, induction of ceramide-mediated 
apoptosis by the anticancer drug doxorubicin in unfertilized mouse oocytes is 
blocked by S1P, but not by dS1P or the ceramide synthetase inhibitor 
Fumonisin B1 (FB1) (7). Moreover, the protective effect of S1P appeared 
entirely independent of the S1P receptors coupled to Gi (123). Although 
several effects of intracellularly generated S1P have been elucidated, the 
direct intracellular targets of S1P remain unclear. 
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Receptor-dependent signaling of S1P 
 
The prototype of the endothelial differentation gene (EDG) -receptor family, 
EDG-1, was cloned in 1990 and soon after, the G-protein-coupled receptors 
EDG -1,3,5,6, and 8 were found to be specific for S1P (113, 124). The high 
affinity S1P receptors EDG -1,3,5,6, and 8, were recently renamed as S1P1, 
S1P2, S1P3, S1P4, and S1P5, respectively (125). Most tissues express one or 
more S1PR subtypes that couple differentially to the G-proteins G1/G0, Gq, 
G12, and G13 with high affinity (115, 117). Binding of S1P to its receptors 
activates diverse signaling pathways, including MAPK and PI3K (126), second 
messenger systems such as cyclic adenosine monophosphate (cAMP) (6) and 
Ca2+ (127), and regulation of the Rho family of small GTPases (important in 
carcinogenesis, proliferation, apoptosis, cytoarchitecture, migration, and 
regulation of transcription factors) (128, 129). Despite the diversity, all S1PR 
affect cell motility, which is an important feature of many physiological and 
pathological processes (110). Indeed, many significant functions of S1P such 
as angiogenesis, vascular maturation, neurite retraction, and heart 
development are mediated through S1PR (130, 131). Whether the regulation 
of apoptosis by S1P is related to its receptors, however, remains unclear. 
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Figure 3. Major signaling pathways of S1PR and intracellularly generated S1P. Several 
important functions of S1P are mediated inside-out through S1PR. These include activation of 
different pathways such as of Rho, adenylatee cyclase (AC), PI3, ERK, and phospholipase C 
(PLC). Intracellularly generated S1P that acts as a second messenger contributes to many 
cellular effects often associated with cell survival independently of S1PR. The specific targets 
of intracellularly generated S1P, however, remain unknown. 
 
 
Sphingolipids as therapeutic agents 
 
Regulation of the sphingolipid rheostat has implications for the treatment of 
cancer, since many cancer treatments, including chemotherapeutic drugs and 
irradiation, cause accumulation of ceramide (91, 110, 132). Manipulation of 
ceramide levels enhance the effectiveness of some cancer therapies by 
selectively enhancing apoptosis of tumor cells. For example, in the liver, 
potent ceramidase inhibitor B13 increases the ceramide content of tumor cells 
and tumor cell apoptosis without affecting the ceramide level or survival of 
normal cells (91). Furthermore, dysregulation of ceramide metabolism may 
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contribute to multidrug, -and radiation resistance of various cancers, since 
increased levels of glycosylceramide and decreased levels of ceramide are 
found in drug-resistant tumors (91). Preventing the degradation of ceramide 
to non toxic metabolites such as glycosylceramide, may therefore increase 
the potency of some chemotheraputic agents (91). Finally, the ability of 
ceramide and ceramide-generating drugs to induce cytotoxity in cancer cells 
lacking p53 suggests that ceramide-based therapeutics are active in some 
cases, where resistance to DNA-damaging agents is high (91). 
 
Blockade of S1P biosynthesis by SPHK inhibitors may be useful in amplifying 
ceramide-mediated apoptosis signals (110). Inhibition of SPHK increases 
induction of apoptosis in cancer cells and enhances sensitivity to gamma 
radiation (110). An inhibitor of SPHK, N,N dimethylsphingosine (DMS) is 
ubiquitous inductor of apoptosis in cancer cells (110). In addition, an analog 
of sphingosine, L-threo-dihydrosphingosine (known as safingol), which also 
acts as an inhibitor of SPHK, enhances doxorubicin accumulation and 
sensitivity in drug resistant breast cancer cell line MCF-7 (110).  
 
In several cell types, radiation acts directly on the plasma membrane, 
activating ASMase, which in turn generates ceramide (132). Recent in vivo 
studies showed that radiation targets ASMase pathway of microvascular 
endothelial cells in the lungs, intestines, brain, and oocytes, initiating the 
pathogenesis of tissue damage (132). In the intestines of mice, the lethal 
gastrointestinal syndrome that limits the efficiency of radiation and 
chemotherapy, could be prevented by genetic inactivation of ASMase and by 
basic fibroblast growth factor (bFGF) that acts in part by suppressing ASMase 
activity (133). In the ovaries of mice, ASMase-deficient oocytes cultured with 
doxorubicin failed to show the signs of apoptosis seen in wild-type (WT) mice 
(7). More importantly, the equivalent level of reduced ovarian germ cell 
apoptosis was achieved by genetic disruption with ASMase and treatment 
with 10 µmol/L S1P ex vivo (7). Consequently, radiation-induced germ cell 
apoptosis was effectively inhibited by in vivo administration of S1P prior to 
0.1 Gy radiation, the amount that usually results in destruction of the 
primordial follicle reserve within 2 weeks (7).  
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Male germ cell apoptosis 
 
 
Spermatogenesis 
 
Spermatogenesis occurs in the seminiferous tubules of the testis, which 
comprises the seminiferous epithelium, the basement membrane and the 
surrounding peritubular myoid cells (Fig. 4). It is characterized as a 
continuous and elaborate maturation process of germ cells towards the 
center of the seminiferous tubules; haploid spermatozoa are produced from 
diploid spermatogonia through mitosis and meiosis (134, 135). Germ cells at 
various phases of differentiation are arranged in defined cellular associations, 
i.e. stages that enter the spermatogenic process at regular time intervals 
(136, 137). The time interval between appearance of the same stage at 
certain points in the tubule extends to about 70 d in humans and 35 d in 
mice (138, 139) and constitutes a single cycle of the seminiferous epithelium 
(134). The number of stages differs between species; 6 stages have been 
defined in humans (134) and 12 in mice (140). In rodents, each particular 
stage occupies a relatively long segment of a seminiferous tubule and 
therefore only one stage is seen in a tubule cross-section making the stages 
easily defined (141). In contrast, stages in the human testis are spirally 
oriented, leading to the typical finding of several irregular cellular associations 
(138).  
 
 
Physiological male germ cell apoptosis 
 
Germ cell renewal to achieve homeostasis, proliferation, export and apoptosis 
must be finely regulated (135). Apoptosis that aims at selective removal of 
dysfunctional or damaged germ cells and at limitation of the germ cell 
number is thus a prerequisite for continuous spermatogenesis (135, 137). 
The first wave of spermatogenesis is initiated when the gonocytes 
differentiate into spermatogonia. While some spermatogonia become self-
renewing spermatogonial stem cells, most differentiate into spermatocytes, 
and at puberty develop by meiosis in to haploid spermatids (135).  
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Figure 4. Schematic illustration of the structure of seminiferous epithelium and the 
interactions between different cell types. Modified from Toppari and Huhtaniemi (142). 
Spermatogonia (sg), spermatocytes (sc) and spermatids (sp) are in close contact with the 
supporting Sertoli cells (S). The cells of the seminiferous epithelium are separated from the 
interstitial tissue by the basal lamina (BL) and peritubular myoid cells (My). Le = Leydig cells, 
B = blood vessel. The arrows demonstrate the paracrinical and/or autocrinical regulation of 
the cells. 
 
 
The first wave of spermatogenesis involves extensive germ cell apoptosis and 
is mediated by signals derived from closely associated Sertoli cells and by 
signals that originate outside the testis (135). In the adult, up to 75% of 
potential spermatozoa degenerate (135). The exact incidence of adult male 
germ cell apoptosis, however, remains unclear, since some dying germ cells 
do not show the classical signs of apoptosis (135).  
 
The early apoptotic wave of spermatogenesis may be required to regulate the 
number of differentiating spermatogonia to fit the capacity of each Sertoli 
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cells to support the developing germ cells (135). The Sertoli cells, possibly 
together with the adjacent basement membrane, create a particular 
microenvironment, termed “niche”, which controls the renewal and 
differentiation of the germ cells by providing nutrition, adhesion and several 
transport functions (135, 138, 143).  
 
Inappropriate male germ cell apoptosis 
 
In male reproductive health, dysregulation of apoptosis is a cause of several 
pathological conditions such as germ cell tumors, cryptorchidism, testicular 
torsion and infertility (144-147). The pathogenesis of these situations involves 
either the inappropriate occurence of apoptosis, or the absence its 
appropriate occurence. In addition, several external disturbances such as 
chemotherapy, radiation, ischemia, toxicant exposure, alterations in hormonal 
support, and elevated temperature may cause excessive male germ cell death 
leading to germ cell loss and infertility (23, 148-153). 
 
Hormonal regulation of male germ cell apoptosis 
 
Gonadotropins (FSH, LH), and testosterone are important regulators of germ 
cell apoptosis (135, 154). Their removal induces apoptosis, which occurs 
presumably through indirect effects, since hormone receptors are present on 
somatic cells (135). 
 
FSH 
FSH is generally considered to be involved in the initiation of pubertal 
spermatogenesis. It regulates DNA synthesis, proliferation, and differentiation 
of spermatogonia and spermiogenesis (15). Observations with FSH-β subunit 
knockout (KO) mice (155) and patients with homozygous mutation of the FSH 
receptor (156), indicate that spermatozoa can be produced without FSH, but 
the number remain small. Thus, while FSH is essential for obtaining a 
quantitatively normal sperm production, it may not be essential for the 
qualitative completion of spermatogenesis (15).  
 
FSH inhibits male germ cell apoptosis in cultured rat seminiferous tubules 
(157), partially via stem cell factor (SCF) produced by Sertoli cells, and 
interacts with the c-kit receptor in the germ cells (158). This mechanism may 
involve changes in the Bcl-2 family members, since in cultured rat 
REVIEW OF THE LITERATURE 
_____________________________________________________________ 
 31
seminiferous tubules either FSH or Sertoli cell-derived SCF can regulate 
antiapoptotic Bcl-w (159, 160). 
 
 
Androgens 
Testosterone, produced by the Leydig cells, plays an indispensable role in 
spermatogenesis (15). High intratesticular, rather than circulating, levels of 
testosterone and adequate expression of androgen receptors in Sertoli cells 
are necessary for the onset of puberty (15). In the human testis, testosterone 
is effectively able to inhibit in vitro-induced apoptosis of spermatocytes and 
spermatids (161). The antiapoptotic action of testosterone may also be 
regulated by some of the testicular metabolites of testosterone, such as 
dihydrotestosterone and estrogens (15). 
 
Estrogens 
Estrogens are potential regulators of male reproduction and germ cell death. 
Low concentrations of 17β estradiol (10-9 and 10-10 mol/L) are able to inhibit 
male germ cell apoptosis in cultured human seminiferous tubules (162). 
Estrogens can also cause alterations in circulating concentrations or 
gonadotropins and testosterone and thus affect apoptosis in germ cells 
indirectly (163, 164). 
 
AP-1 in the testis 
 
Several studies suggest the presence of diverse functions of AP-1 in testis 
development and functions. In the germ cells of mouse testis, AP-1 proteins 
are expressed in a developmental stage-specifical manner (165). JNK 
participates in the regulation of mouse spermatogenesis (166) whereas 
ERK1/2 is induced in sperm maturation (167) and capacitation (168).  
JunD -/- male mice exhibit multiple age-dependent defects in reproduction, 
hormone imbalance, and impaired spermatogenesis, with abnormalities in 
head and flagellum sperm structures (169). The role played by AP-1 in the 
regulation of male germ cell apoptosis remains unclear. 
 
NF-κB in the testis 
 
In the rat testis, NF-κB is expressed in the nuclei of Sertoli cells at all stages 
of spermatogenesis, the intensity of expression varying between the stages 
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(170). TNFα induces activation of NF-κB, which may lead to the activation of 
cAMP response element binding protein (CREB) that has been suggested to 
be a regulator of spermatogenesis (171). In the human testis, low basal NF-
κB DNA-binding activity is present in the seminiferous epithelium, and is 
localized in the Sertoli cells (83). During in vitro-induced apoptosis of 
seminiferous tubules, the Sertoli cell nuclear NF-κB expression and entire 
seminiferous tubule NF-κB DNA binding activity increase strongly and rapidly 
before the onset of nuclear germ cell apoptosis (83). Induction of NF-κB DNA 
binding is completely blocked by the anti-inflammatory drug sulfasalazine 
concomitantly with suppression of germ cell apoptosis (83).  
 
Sphingolipid pathway in the testis 
 
The SM pathway regulates several functions of somatic testicular cells. In 
porcine Sertoli cells, it participates in the production of lactate, a crucial 
metabolite for germ cells (172). In rat Leydig cells, the ceramide-dependent 
pathway regulates hCG-stimulated Leydig-cell steroidogenesis at the level of 
cAMP production and at post-cAMP events (173). In the same cells, ceramide 
generation is completely blocked by the ceramide synthetase inhibitor FB1 
and exogenous ceramide itself induces apoptosis (174). The role played by 
the SM pathway in the regulation of spermatogenesis has remained unclear. 
ASMKO mice lacking one of the enzymes that convert SM to ceramide, have 
pathological testicular tissue and sperm due to lipid accumulation (175); the 
germ cells, however, appear normal (175).  
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Aims of the study
Sphingolipids are powerful mediators of diverse cellular processes and thus
hold great promise in different fields of cancer research (5). The sphingolipid
metabolite S1P is able to inhibit apoptosis in several cell lines and appears to
be promising in the means of protection for ovaries against cancer treatments
(7). The best way to preserve fertility of prepubertal boys would be to protect
the spermatogenic stem cells against apoptosis induced by cancer treatments
in vivo. The present series of studies therefore aimed at elucidating the
inhibitory potential and inhibitory mechanisms of S1P on male germ cell
apoptosis and the ability of S1P to prevent radiation-induced male germ cell
loss. In particular, the following issues were addressed:
1. The inhibitory effect of S1P in vitro on male germ cell apoptosis of the
human testis in a culture of seminiferous tubules. 
2. Characterization of the mechanisms, by which S1P inhibits male germ cell
apoptosis in vitro, with emphasis on the roles of S1PRs and intracellularly
generated S1P, and on transcription factors involved in the regulation of male
germ cell apoptosis.
3. The potential ability of S1P in vivo to protect against radiation-induced male
germ cell death in an experimental animal model. 
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Materials and treatments  
 
 
I In vitro studies 
 
 
 
Patients 
 
Testicular tissue was obtained from 47 men aged 59-80 years of age 
undergoing orchidectomy as a treatment for prostate cancer. These 
patients had received no hormonal, chemotherapeutic, or radiotherapeutic 
treatments before the operations. They had no endocrinological disease 
and none had suffered from cryptorchidism. The testicular tissue was 
prepared for culture immediately after the operations, which were 
performed between December 1999 and August 2003 at the Department 
of Urology, Helsinki University Central Hospital (Helsinki, Finland). The 
ethics committees of the Hospital for Children and Adolescents and the 
Department of Urology, University of Helsinki, approved the study 
protocol. 
Study design  
Tissue culture. Germ cell apoptosis of the human testis was induced by 
incubating segments of seminiferous tubules under serum-free conditions. 
To maintain the physiological contact between the Sertoli cells and the 
germ cells, segments of seminiferous tubules rather than isolated 
testicular cells were cultured. The testicular tissue was microdissected in a 
Petri dish containing culture medium supplemented with 0.01% human 
serum albumin and 10 µg/mL gentamicin. Segments (~2 mm in length) of 
seminiferous tubules were transferred to a Petri dish containing the same 
serum-free culture medium and incubated for 0-10 h at 34 °C in a 
humidified atmosphere containing 5% CO2. Since human testicular tissue is 
rather dense, some interstitial tissue with occasional Leydig cells were 
present in the culture. Immunohistochemical studies from cultured 
samples (II-III) were performed from the small (0.05-0.85 g) tissue 
samples that were cultured under serum-free conditions as described. 
Since the testis tissue was not homogenous, the immunohistochemically 
best part of the slide was used for further evaluation. 
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Treatments 
  
Descriptions of the use of the following compounds are detailed in the 
original publications (I-III). The effects of these compounds on germ cell 
apoptosis were studied by adding them to the culture medium prior to the 
5-h culture under serum-free conditions at the concentrations indicated: 
S1P (1 µmol/L, 10 µmol/L, 20 µmol/L), the ceramide synthetase inhibitor 
FB1 (100 µmol/L, 250 µmol/L), N-Acetyl-L-cysteine (NAC; 100 mmol/L), 
potassium cyanide (KCN; 50 mmol/L), desipramine (10 µmol/L, 50 
µmol/L), imipramine (10 µmol/L, 30 µmol/L), recombinant human FSH 
(0.01 IU/ml, 0.1 IU/ml, 1.0 IU/ml), 17 β estradiol (E2; 10–10 mol/L), 
specific JNK inhibitor SP600125 and specific MEK inhibitor PD98059 (10 
µmol/L, 50 µmol/L, 100 µmol/L), dS1P (1µmol/L, 10 µmol/L, 20µmol/L). 
 
II In vivo study 
 
Mice 
 
WT C57BL/6 young adult male mice, 8-10 weeks of age, were obtained 
from the University of Helsinki experimental animal facilities. All animal 
experiments were approved by the Institutional Animal Care and Use 
Committee of the Wihuri Research Institute, Helsinki Finland. 
 
Study design 
 
In the experiments, the mice were anesthetized by intraperitoneal 
injection of 600–800 µL 1.25% Avertin [2,2,2-tribromoethanol in tert-
Amyl-Alcohol; 1600 mg/mL] 1-2 h before irradiation, after which they 
received a dose of 0, 0.1, 0.5, 1.0, or 2.0 Gy whole-body irradiation at the 
Department of Oncology, Helsinki University Hospital, Helsinki, Finland. 
Irradiation was performed with a Varian Clinac 600C linear accelerator 
using a 6-MV photon beam and a dose rate of 2 Gy/min. The mice were 
placed in the prone position in a plastic box and irradiated by means of a 
single posterior field covering the entire box plus a 2-cm margin to 
achieve maximum uniformity of dose distribution. The absorbed dose was 
calculated at a depth of 2 cm. In addition, a 1.5-cm-thick plexiglass 
absorber was added at the entrance side of the field to obtain a full dose 
build up. Sixteen hours after irradiation, the tissue samples were fixed in 
2.5% glutaraldehyde for electron microscopic studies and after 21 d, the 
testes were weighed and DNA flow cytometric analyses were performed. 
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Irradiation experiments: At the 16-h time point after 0, 0.5, or 1.0 Gy 
irradiation, the mice were anesthetized by CO2 and sacrificed by cervical 
dislocation. The tissue samples were collected in 2.5% glutaraldehyde for 
electron microscopic studies. At the 21-d time point, after 0, 0.1, 0.5, 1.0, 
or 2.0 Gy irradiation, the mice were sacrificed as described, the testes 
weighed and after stage-specific preparation of seminiferous tubules, DNA 
flow cytometric analyses were performed. 
S1P experiments: Description of the use of S1P is detailed in the original 
publication (IV). For the control group of animals, the vehicle (PET-PBS) 
was injected intratesticularly into the right testis, while the left testis 
remained as an untreated control. For S1P-treated mice 30 µL of 50 
µmol/L S1P in PET-PBS was injected into the right testis and 30 µL of 200 
µmol/L S1P in PET-PBS into the left testis.  
At the 16-h timepoint, the effect of S1P on 0.5 Gy radiation-induced rapid 
germ cell death was studied with in situ end-labeling (ISEL) analysis of 
DNA fragmentation. After radiation doses of 0.5 and 1.0 Gy, the tissue 
samples were also collected in 2.5% glutaraldehyde for electron 
microscopic studies. At the 21-d timepoint, after stage-specific preparation 
of seminiferous tubules, the long-term effects of S1P on 0.5 Gy radiation-
induced apoptosis were studied with DNA flow cytometry. 
Seminiferous tubule preparations. Sixteen hours or 21 d after total body 
irradiation, the testes were decapsulated in PBS in a Petri dish, the 
seminiferous tubules were gently teased apart, and three 1-mm-long 
segments of seminiferous tubules at each of the stages II–V, VI–VIII, and 
IX–XII per mouse were prepared under a transillumination 
stereomicroscope (140, 176, 177). 
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Methods 
 
Laboratory analyses 
 
Analysis of testicular levels of ceramide and sphingomyelin  
 
The levels of SM and ceramide were measured from seminiferous tubules 
after a 5-h induction of apoptosis. Small samples of human testis tissue 
were homogenized in homogenization buffer and the supernatants 
collected for determination of protein concentration by the DC protein 
assay. Human testis tissue lipids were extracted by the modified method 
of Bligh & Dyer (178). The lipids were dissolved in chloroform:methanol 
(2:1, v/v) and analyzed by high performance thin-layer chromatography 
(HPTLC) on an HPTLC silica gel 60 plate. Densitometric scanning of the 
bands and evaluation of the data were performed with an automatic plate 
scanner (CAMAG TLC Scanner no. 3) and CAMAG TLC Software, 
respectively. The amounts of ceramide and SM were compared with the 
total amount of cell protein, and the ceramide:SM weight ratio was 
calculated.  
 
In vitro acid sphingomyelinase activity assay 
 
 
Small samples of human testis tissue were homogenized in 1000 µL of 
homogenization buffer and the supernatants were collected for protein 
concentration determination with the DC protein assay. The protein 
homogenate (100 µg) was mixed with 100 µL of ASMase buffer containing 
40 000 cpi [14C] SM and incubated for 1 h at +37 °C. The reactions were 
stopped by addition of 1.5 mL chloroform:methanol (2:1, v/v) plus 200 µL 
of distilled water and vortexing. After centrifuging at 1800 g for 5 min, 300 
µL of the upper aqueous phase containing the released radioactive 
phosphorylcholine was transferred to scintillation vials for determination of 
radioactivity in a liquid scintillation counter. Negative controls containing 
no enzyme were assayed simultaneously. 
 
 
Detection of apoptosis 
Southern blot analysis of apoptotic DNA fragmentation. DNA was 
extracted with the apoptotic DNA Ladder Kit (Roche Molecular 
Biochemicals, Mannheim, Germany) as described (162). After the DNA 
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was quantified spectrophotometrically, 1 µg of the total DNA from each 
sample was subjected to 3´end-labeling with digoxigenin-dideoxy-UTP 
(dig-dd-UTP) in the terminal transferase reaction. The DNA samples were 
electrophoresed on 2 % agarose gels, blotted onto nylon membranes, and 
cross-linked to the membranes with UV irradiation. The membranes were 
then washed and blocked with 1% blocking reagent in maleic acid buffer. 
The 3' end-labeled DNA in the membranes was localized and the bound 
antibody was detected with the chemiluminescense reaction (CSPD).  
 
Caspase 3 activation. The activity of caspase 3 was measured with the 
Caspase 3 fluorometric assay kit (RD Systems, Minneapolis, MN, USA) 
according to the manufacturer’s instructions. Briefly, samples of human 
testis tissue were homogenized in lysis buffer, centrifuged at 17 000 g for 
20 min, and the supernatants collected for determination of protein 
concentration using the DC protein assay. Thereafter, 100 µg of protein 
homogenate in 50 µL lysis buffer, 50 µL of reaction buffer 3, and 5 µL 
Caspase-3 fluorogenic substrate (DEVD-AFC) were added to 96-well 
plates, and the plates were incubated at + 37 °C for 2 h. Finally, the 
fluorescence was measured on a fluorescence microplate reader (Perkin 
Elmer HTS 7000 Plus Bio Assay Reader) using 405-nm excitation and 505-
nm emission filters. For negative controls, the fluorescence was measured 
from wells containing no substrate or no protein homogenate. 
 
 
Nonradioactive in situ 3´end-labeling of DNA. Small segments of 
seminiferous tubules (~1-2 mm in length) were squashed under coverslips 
to produce a monolayer of cells, and the preparations were fixed and 
rehydrated as previously described (177). After incubation for 10 min with 
terminal transferase reaction buffer, the apoptotic DNA was 3´end-labeled 
with dig-dd-UTP by the terminal transferase reaction. For the negative 
controls, the terminal transferase enzyme was replaced with the same 
volume of distilled water. The dig-dd-UTP was detected with the 
antidigoxigenin antibody conjugated with horseradish peroxidase. For 
location of the antibody, 0.05% diaminobenzidine substrate was added. 
Light counterstaining was performed with hematoxylin, and the samples 
were dehydrated and mounted.  
 
Immunohistochemistry
 
The immunostainings were performed on 5-h cultured or non cultured 
paraffin-embedded sections of formalin-fixed adult testicular tissues. The 
paraffin sections were deparaffinized in xylene and the sections were then 
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rehydrated and microwaved in citrate buffer for antigen retrieval. The 
samples were subjected to immunohistochemistry by the antibodies 
described in Table 1 and the antibodies were used at concentrations of 
0.5-0.8 µg/mL. The primary antibodies were added to the samples and 
incubated overnight at 4 °C and detected with biotin-conjugated goat anti-
rabbit or rabbit anti-mouse IgG from the ABC-Elite kit (Vector laboratories, 
Inc., Burlingame, CA, USA), followed by incubation with ABC solution. For 
location of the secondary antibody, 0.05% diaminobenzidine substrate 
was added. For the negative controls, the primary antibodies were 
replaced with nonimmune rabbit or mouse IgG.  
 
 
Table 1. Antibodies used in immunohistochemistry, EMSA, and Western 
blotting 
 
Antibody Clonality Source use 
p-c-Jun PC Santa Cruz Biotechnology;sc-822 IH, EMSA 
c-Fos MC Santa Cruz Biotechnology;sc-52 IH, EMSA 
JunD MC Santa Cruz Biotechnology;sc-74 IH, EMSA 
JunB PC Santa Cruz Biotechnology;sc-46 EMSA 
EDG-1(S1P1) PC Santa Cruz Biotechnology;sc-16070 IH 
EDG-1(S1P2) PC Santa Cruz Biotechnology;sc-16085 IH 
p-ERK1/2 PC Cell Signaling Technology 9910 IH 
ERK PC Santa Cruz Biotechnology;sc-94 IH 
IκBα PC Santa Cruz Biotechnology;sc-847 WB 
Akt PC Cell Signaling Technology 9271 WB 
p-Akt PC Cell Signaling Technology 9271 WB 
 
MC = Monoclonal 
PC= Polyclonal 
IH = Immunohistochemistry 
EMSA = Electric mobility shift assay supershifts 
WB = Western blotting 
 
Electron microscopy 
 
Segments of the seminiferous tubules were fixed in 2.5% glutaraldehyde 
in 0.1 mol/L phosphate buffer, dehydrated, and embedded in epoxy resin. 
The tissue blocks were sectioned at 50 nm with an ultramicrotome and 
stained with uranyl acetate and lead citrate. The samples were examined 
with a JEOL JEM 1200 EX transmission electron microscope (JEOL, Tokyo, 
Japan) at the Institute of Biotechnology, Electron Microscopy Unit, Finland. 
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Protein extracts 
 
For cytoplasmic and nuclear protein extracts, the seminiferous tubules 
were gently homogenized with a tight-fitting Potter-Elvehjelm 
homogenizer into ice-cold hypotonic buffer, and the protein extracts were 
prepared as previously described (179). For whole-cell protein extracts, 
small tissue sections were homogenized with an Ultra-Turrax T8 
homogenizer on ice in homogenization buffer. The protein concentrations 
from the supernatants were determined using the DC protein assay. 
Western blotting 
 
The proteins (50 µg) were loaded onto SDS-polyacrylamide gels and 
electrophoresis was performed at 180 V. The proteins were transferred to 
polyvinylidene difluoride membranes by electrophoresis for 2 h at 4 °C in 
transfer buffer at 100 V. The transfer was checked by staining with 0.2% 
Ponceau S in 3% trichloroacetic acid. The primary antibodies (Table 1) 
against the proteins under investigation were used at 0.2 µg/mL. The 
primary antibodies were followed with peroxidase-conjugated goat anti-
rabbit or goat anti-mouse IgG. The bound secondary antibodies were 
located with an electron chemiluminescence (ECL) detection kit. 
Electron mobility shift assay 
 
The AP-1 and NF-κB DNA binding activities were assayed by DNA probe 
containing the consensus AP-1 site 5´GATCTATCTGAGTCAGCAG-3 (180) 
and the consensus κB enhancer element 
5´AGTTGAGGGGACTTTCCCAGGC-3. The probes 5´end-labeled with [γ-32P] 
ATP using polynucleotide kinase (15 000-30 000 cpm) were incubated 
with testicular protein nuclear extracts (10 µg) and thereafter, the reaction 
products were separated on 4% polyacrylamide gels at 200 V at room 
temperature. In the competition experiments, a 100-fold molar excess of 
unlabeled probe was added prior to the labeled probe. After 
electrophoresis, the gels were dried and visualized by autoradiography. In 
the supershift assays, 2 µg of an affinity-purified polyclonal antibody 
(Table 1) was added after the binding reactions, and incubation was 
further continued for 1 h at room temperature.  
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DNA flow cytometry 
 
DNA flow cytometric analyses after irradiation were performed as 
described previously, with some modifications (140, 181). Stage-specific 
1-mm-long single segments of seminiferous tubules were treated with a 
detergent and ribonuclease A for 10-15 min at 4 °C, followed by a 10 sec 
vortex mix and incubation for 10 min at 37 °C. Propidium iodide (25 
µg/mL) was added to the samples for staining of the nuclei, and 10 µL of 
diluted fluorescent particle solution (500 beads/µL, TrueCount Beads, 
Becton Dickinson, Mountain View, CA, USA) was added to each sample as 
an internal volume standard for the quantification of absolute cell 
numbers. The samples were filtered through 45-µm metal strainers and 
200 µL of PBS was added to each sample to increase the volume. The 
samples were analyzed with a FACSCalibur flow cytometer (Becton 
Dickinson) using an excitation wavelength of 488 nm. A total of 5000 
fluorescent impulses were counted, excluding the beads that were gated 
out of the rest of the sample. The number of nuclei in each peak of the 
DNA histograms were calculated using CellQuest Pro software (Beckton 
Dickinson) and converted to absolute numbers using the internal standard. 
The 1C population consisted of step I-XII spermatids. The 1C´ population 
consisted of step XIII-XVI spermatids that bound less propridium iodide 
than step I-XII spermatids and therefore formed a hypohaploid peak. The 
4C population consisted mainly of primary spermatocytes (except for 
preleptotene spermatocytes that were dispersed in the S-phase and the 
2C peak, depicting chromatin synthesis and diploid chromatids, 
respectively) but also of spermatogonia (G2/M) (140). 
 
 
Quantitative analyses of x-ray films 
 
In the original publications (I-III), the X-ray films exposed to 
chemiluminescence (Southern blots), autoradiography (EMSA), or ECL 
(Western blots) were scanned with a tabletop scanner (Hewlett Packard 
Scan Jet 6300C) and the digital image was analyzed with the gel plot 2 
macro for Scion image β 4.0.2. (Scion Corp., Frederic, MD, USA) analysis 
software. For the Southern blots, digitized quantification of the low-
molecular-weight DNA fragments (< 1.3 kB) in the sample cultured for 10 
h (in the time-course analyses of nuclear apoptosis) or for 5 h (in the S1P-
, FB1-, desipramine-, imipramine-, FSH-, NAC-, E2-, dS1P-, PD 98059-, 
and SP 600125-treated samples) without treatments was taken as 1.0 
 41
METHODS 
___________________________________________________________ 
 42
 
.
(100% apoptosis), and the amounts of low-molecular weight DNA 
fragments in the other samples were expressed in relation to this. For 
time-course analysis of AP-1 activation (EMSA), digitized quantification of 
the specific AP-1 band in the sample cultured for 5 h was set as 1.0 and 
the intensities of the bands in other samples were expressed in relation to 
this.  
 
 
Statistics 
 
I In vitro studies 
 
Statistical analyses were performed based on at least 3 independent 
experiments. Data obtained from 3-11 cultures (mean ± SEM) were 
analyzed by one-way analysis of variance (ANOVA), and if significant 
differences existed this was followed by comparison of the groups with the 
two-tailed unpaired Student t-test. A value of P < 0.05 was considered 
statistically significant. 
 
II In vivo study 
Sixteen hour time point  The Mann-Whitney test was used to test 
differences in apoptotic cell counts between the S1P-treated and non-
treated groups. 
Twenty-one-day time point. Differences in cell numbers between the 
radiation dose groups within the 3 stages among the 1C and 4C 
populations, effect of S1P on cell numbers and the effect of radiation dose 
on testicular weight were tested with ANOVA followed by Dunnett’s test.  
Values of P < 0.05 were considered significant. Results were expressed as 
mean ± SEM. 
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Results 
 
 
Induction of human male germ cell apoptosis in vitro 
 
Germ cell apoptosis was induced by incubating the seminiferous tubule 
segments under serum-free culture conditions. The different types of 
human testicular cells undergoing apoptosis were previously characterized 
by ISEL and electron microscopy: apoptosis occurs mainly in the germ 
cells i.e. the spermatids and early spermatocytes, whereas the Sertoli cells 
are rather resistant to apoptosis (161, 182-185).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Low-molecular-weight DNA fragmentation. Culturing the seminiferous 
tubule segments under serum-free conditions resulted in induction of 
apoptotic DNA fragmentation within 5 h, which further increased at 48 h 
as measured with Southern blot analysis of the low-molecular-weight DNA 
fragmentation (Fig. 1C in I, Fig. 1A in II).  
Ceramide levels. During the seminiferous tubule culture the level of 
ceramide increased within 1 h and at 2.5 h, it had almost attained 
maximum (Fig. 1A-B in I).  
Caspase 3 activity. The time course activation of caspase 3 during human 
testicular apoptosis was measured from samples incubated under serum-
free conditions from 15 min to 10 h. Caspase 3 activity began to increase 
after 1 h (Fig. 1B in I, Fig. 1C in III).  
Activator protein 1 DNA-binding activity. AP-1 DNA-binding activity was 
clearly increased at the 2.5 h time point and was further elevated at the 5-
h time-point, after which it bagan to decrease (Fig 1B in II, Fig. 3B in III). 
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Figure 5. Time course of activation of in vitro -induced human testicular apoptosis.  
Segments of seminiferous tubules were cultured under serum-free conditions for 0-10 h 
to induce apoptotic cell death, after which apoptotic DNA fragmentation, AP-1 DNA-
binding activity, and caspase 3 activation were measured. A a: Southern blot analysis of 
low-molecular-weight DNA (< 1.3 kb) fragmentation. DNA was extracted, after which 1 
µg of the total DNA from each sample was 3´end-labeled with dig-dd-UTP and subjected 
to electrophoresis. The labeled DNA was detected with chemiluminescence. b: Low-
molecular-weight DNA (< 1.3 kb) fragmentation was quantified from the radiographs 
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and plotted as a function of time. Induction of apoptotic DNA fragmentation occurred 
within 5 h and further increased at 10 h. The digitized quantification of the low-
molecular-weight DNA fragments in the sample cultured for 10 h (maximal optical 
density) was taken as 100%, and the amounts of low-molecular-weight DNA fragments 
in the other samples were expressed in relation to this. B. Lipids from seminiferous 
tubules cultured for 0-10 h were extracted and ceramide and SM in the samples 
quantified. C. Time course activation of caspase 3 during human testicular apoptosis 
from samples incubated under serum-free conditions for 0-10 h. Caspase 3 activity 
increased steadily after 1 h. Data represent 2 independent experiments. D a: EMSA 
demonstrating the increase in AP-1 DNA-binding activity during in vitro-induced testicular 
apoptosis. Nuclear protein extracts (10 µg) from the seminiferous tubules were 
incubated with 32P-labeled AP-1 oligonucleotide, and the DNA-protein complexes formed 
were resolved on polyacrylamide gel electrophoresis. b: AP-1 DNA binding was 
quantified from the radiographs and plotted as a function of time. The digitized 
quantification of the specific AP-1 band in the sample cultured for 5 h (maximal optical 
density) was taken as 100% and the intensities of the other bands were expressed in 
relation to this.  
 
Generation of ceramide  
 
 
 
 
 
Role of acid sphingomyelinase  
 
Although ASMase activity was suppressed by 38.5 % and 17.6 % with 
desipramine and imipramine, respectively, neither of the ASMase 
inhibitors used significantly effected testicular germ cell apoptosis or the 
level of testicular ceramide (I). 
Effect of Fumonisin B1  
 
No significant effects of FB1 (100 µmol/L or 250 µmol/L) on germ cell 
apoptosis were observed in Southern blot analysis of DNA fragmentation 
(Fig. 2 in I). The levels of ceramide and SM in FB1-treated seminiferous 
tubules were decreased by 25% and 24%, respectively (P < 0.01). 
However, the ceramide:sphingomyelin ratio did not differ from that of 
control samples cultured under serum-free conditions without treatments.  
Potassium cyanide and N-Acetyl-L-cysteine  
 
After 5-h culture, NAC and KCN suppressed low-molecular-weight DNA 
fragmentation by 78% and 64%, respectively (P < 0.05), but had no 
significant effect on testicular ceramide levels (Figs. 3B and 4B, I).  
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Effect o  S1P in vitro 
Role of intracellularly generated S1P  
 
Addition of exogenous S1P to the culture caused evident inhibition of
germ cell death. The most effective antiapoptotic concentration was 10 
µmol/L, which suppressed low molecular weight DNA fragmentation by 
30% (P < 0.001; Fig. 3A in I, Fig. 2A in II). ISEL analysis consistently 
showed a reduced number of apoptotic cells in the samples incubated with 
exogenous S1P, with no apparent abnormalities in the morphology of the 
germ cells (Fig 3. in I). To quantify the effect of S1P with yet another 
independent mechanism, we found that S1P was able to inhibit caspase 3 
activation by 15% (P < 0.05) (Fig. 3 in I). 
 
In contrast, dS1P, a S1P analog that like S1P activates the S1PRs but 
unlike S1P does not penetrate the cell membrane, did not inhibit apoptotic 
DNA fragmentation when used at a concentration (10 µmol/L) similar to 
that of S1P. The amount of DNA fragmentation in dS1P-treated samples 
was 108% compared with the non treated, 5-h-cultured samples (P = NS; 
Fig. 2 in II).  
Expression of S1P1 and S1P 2 receptors  
 
Antibodies against S1P1R and S1P2R showed similar cytoplasmic staining 
patterns. Positive cytoplasmic immunostaining in the Sertoli cells was 
observed in the majority of the cross sections of the seminiferous tubules. 
Occasional germ cells, mainly spermatogonia and early meiotic 
spermatocytes, also expressed weak cytoplasmic immunostaining (Fig. 1 
in II).  
 
S1P but not dS1P inhibits NF-κB DNA binding and phosphorylation of Akt 
 
Seminiferous tubules cultured for 5-h with 10 µmol/L S1P showed almost 
complete suppression of NF-κB DNA-binding activity as measured by 
EMSA (Fig. 3A in II). In contrast, in tubules cultured for 5 h with 10 
µmol/L dS1P, no effect on NF-κB DNA-binding activity could be seen 
compared with the non treated samples (Fig. 3A in II). 
 
Western blot analysis of the cytoplasmic extracts from uncultured 
seminiferous tubules and seminiferous tubules cultured for 5 h in the 
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presence or absence of 10 µmol/L S1P or dS1P showed intensive IκBα 
expression in the uncultured tubules and clearly diminished IκBα 
expression in the tubules cultured for 5 h without treatments. In the 
tubules treated with S1P, inhibition of IκBα degradation was more evident 
than in the tubules treated with dS1P (Fig.4 in II). 
 
Western blot analysis of Akt showed that active, i.e. phosphorylated Akt 
(p-Akt), was strongly expressed in uncultured seminiferous tubules, 
whereas in the 5-h-cultured tubules the expression of p-Akt was clearly 
diminished. In the S1P-treated, 5-h-cultured tubules, the expression of p-
Akt was almost totally absent. In contrast, phosphorylation of Akt was 
evident in the dS1P-treated, 5-h-cultured samples. Equal amounts of 
inactive Akt were detected in the uncultured, 5-h-cultured untreated, and 
5-h-cultured, S1P- or dS1P-treated seminiferous tubules (Fig. 4 in II). 
 
AP-1 activity in the human testis 
 
AP-1 DNA-binding activity increased at the 2.5 hour time point during 
culture of seminiferous tubules, and was further elevated at the 5 h time 
point, after which it began to decrease as measured by EMSA (Fig. 1B in 
III). All the AP-1 proteins detected at various time points gave a similar 
staining pattern. After 2.5-h or 5-h-culture under serum-free conditions, 
the Sertoli cells in most of the seminiferous tubules expressed nuclear AP-
1 (Fig. 3 in III). In non cultured seminiferous tubules, some 
spermatogonia and early meiotic spermatocytes expressed cytoplasmic 
immunostaining for JunD and c-Fos. Participation of the AP-1 transcription 
factors c-Jun, JunD, and c-Fos in formation of the DNA-protein complexes 
was further elucidated by the EMSA supershift assays. Incubation of the 
nuclear extracts with antibodies against c-Jun, JunD, and c-Fos, but not 
with antibody against JunB, resulted in supershifts of the basal DNA-
protein complexes (Fig. 2 in III). 
 
To specify the effects of MAPK kinases on testicular tissue, we tested the 
effects of the specific inhibitors of ERK and JNK, PD98059 and SP600125, 
respectively, during induction of human male germ cell apoptosis. As 
measured in Southern blot analysis of DNA fragmentation and with AP-1 
DNA-binding activity, neither PD98059 nor SP600125 affected male germ 
cell apoptosis or AP-1 DNA-binding activity (unpublished data). 
 
 47
RESULTS
________________________________________________________________
48
S1P and activation of ERK 
In non cultured seminiferous tubules, some Sertoli cells expressed weak
cytoplasmic immunostaining of the phosphorylated, i.e. active ERK protein
(p-ERK). After 5 h culture in the presence or absence of S1P or dS1P, the
Sertoli cells in most of the seminiferous tubules detected expressed
cytoplasmic p-ERK. However, positive staining was more intense in tubules
treated with S1P and dS1P, especially with the latter (Fig. 5 in II).
Expression of ERK representing the overall levels of ERK was similar in the
samples cultured for 5 h with or without treatments; strong expression of
ERK was found in the cytoplasm of both the germ cells and Sertoli cells
(Fig. 5 in II).
Effects of FSH, NAC, E2 and S1P 
FSH, at 1.0 IU/mL inhibited testicular apoptosis by 35% (P < 0.05) and
concomitantly suppressed AP-1 DNA-binding activity (Fig. 4A-B in III). In
the samples from 2 independent cultures, however, we observed that
although FSH suppressed AP-1 DNA-binding activity, it did not affect NF-
κB DNA-binding activity (Fig. 4C in III). 
E2 at a concentration of 10-10 mol/L inhibited apoptosis by 56% but did
not reduce the AP-1 DNA-binding activity below the level detected in
control samples (testicular tissue cultured for 5 h without treatments).
Likewise, E2 did not affect NF-κB DNA-binding activity (Fig. 5 in III). At a
concentration of 100 mmol/L, NAC inhibited apoptosis by 78% and
concomitantly suppressed AP-1 DNA-binding activity almost to the basal
level (Fig. 5 in III). We previously showed that NAC does not affect NF-κB
DNA-binding activity (83).
Neither S1P nor dS1P affected AP-1 DNA-binding activity; similar activity
was detected in tubules cultured for 5 h under serum-free conditions with
or without 10 µmol/L S1P or dS1P (Fig. 3 in II).
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Table 2. Regulation of in vitro-induced male germ cell death 
 
Compound Function Male germ cell death 
Generation
of ceramide
AP-1 
activity 
NF-κB 
activity 
Sphingolipid pathway      
S1P Survival factor ↓ ? ↔ ↓ 
dS1P S1P analog that binds to S1PR ↔ ? ↔ ↔ 
Fumonisin B1 
Inhibitor of de 
novo ceramide 
pathway 
↔ ↔ ? ? 
Imipramine Inhibitor of ASMase ↔ ↔ ? ? 
Desipramine Inhibitor of ASMase ↔ ↔ ? ? 
Hormones      
17β estradiol Survival factor ↓ ? ↑ ↔ 
FSH Survival factor ↓ ? ↓ ↔ 
Regulators of ROS      
NAC 
Glutathione 
precursor, 
antioxidant 
↓↓ ↔ ↓ ↔ 
KCN Regulator  of ROS ↓↓ ↔ ? ? 
MAPK inhibitors      
PD 98059 MEK inhibitor ↔ ? ↔ ? 
SP 600125 JNK inhibitor ↔ ? ↔ ? 
 
↔ No effect 
? Not tested 
 
In vivo effect of S1P on radiation-induced male germ cell loss  
 
 
 
Sixteen hours after irradiation 
Effect of S1P. As detected by electron microscopy, S1P in itself dit not 
appear to induce morphological changes in S1P-treated segments of 
seminiferous tubules, since although occasional apoptotic cells (mainly 
spermatogonia) were observed, most of the germ cells had retained their 
normal appearance (Fig. 2D-E in IV). 
In stage-specific squash preparations for ISEL of DNA fragmentation, no 
statistically significant differences were found between the non treated 
and 50 µmol/L or 200 µmol/L S1P-treated groups, although a statistically 
non significant trend towards lower amounts of ISEL-positive cells was 
detected in stages II–V and IX–XII (Fig. 5A in IV). 
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Twenty-one days after irradiation 
 
 
Testicular weight. The weights of the testes decreased 21 d after 
irradiation. A significant decrease in testis weight was already seen after 
0.5 Gy radiation, the weight being 77% (P < 0.05) of the non irradiated 
testes. After 2.0 Gy, the decrease in testis weight was 44% (P < 0.05) 
(Fig. 1 in IV). 
Effect of S1P. The number of cells in the 1C and 4C populations markedly 
decreased with increasing dose of irradiation. S1P was not able to inhibit 
the reduction of apoptotic cells in the1C population. In contrast, the 
numbers of cells in the 4C population in samples from irradiated plus S1P-
treated animals were not significantly lower at any stage (II–V, VII–VII, 
and IX–XII) than the numbers of 4C cells in non-irradiated controls (Fig. 6 
in IV), indicating that S1P was able to inhibit apoptosis of the early 
spermatogonia. More precisely, at stages II–V the cell numbers from S1P-
treated animals were 16% and 34% higher after treatment with 50 
µmol/L and 200 µmol/L S1P, respectively, than in irradiated and vehicle-
treated animals. At stages VII–VIII this effect of S1P treatment was 
clearer, the total cell numbers being 35% and 47% higher. Finally, at 
stages IX–XII, the cell numbers in S1P-treated animals were 40% and 
38% higher than in vehicle-treated animals. 
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Figure 6. Schematic illustration of the structure of mouse seminiferous epithelium. Modified from 
Pentikäinen et al. (162) and Yan et al. (186). Differentiation of early spermatogonia to spermatocytes 
and to spermatids lasts approximately 9 and 18 d, respectively (arrows). Spermatogonia dying of 
radiation-induced apoptosis are shown with a light gray background. Twenty-one days after 
irradiation, apoptosis of spermatogonia damaged at the time of irradiation is observed as a reduction 
in the 4C population of spermatocytes and the 1C population of spermatids (dark gray background). 
The population of spermatogonia (Apr) that are preserved against radiation–induced germ cell 
damage by S1P are presented with the lightest gray. The preservation of these cells is observed as a 
non reduced number of 4C population of spermatocytes (dark gray) 21 d after irradiation. The specific 
cell associations in the vertical columns represent spermatogenic stages of the epithelial cycle (Roman 
numerals). Apr, A-paired spermatogonia; Aal, A-aligned spermatogonia; A1-A4, type A1-4 
spermatogonia; In, intermediate spermatogonia; B, type B spermatogonia; PI, preleptotene 
spermatocytes; L, leptotene spermatocytes; Z, zygotene spermatocytes; Sp, spermatocytes; Di, 
diplotene spermatocytes; M, meiotically dividing spermatocytes; Sd, spermatids. 
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Discussion 
 
Methodological aspects 
 
In vitro studies 
 
Male germ cell death was induced in a culture model that has many 
limitations. The model was most likely not capable of supporting the 
process of spermatogenesis, thus representing a dying model. It, 
however, aimed at representing a stress situation in which the reactions of 
different cell types in the seminiferous epithelium during severe stress 
could be evaluated. Although the primary inductor of cell death was serum 
deprivation, other simultaneous inductors, such as relative hyperoxia, 
activated parallel apoptotic pathways. In addition, prolonged stress most 
probably led to activation of secondary apoptotic pathways and the cells 
treated with antiapoptotic compounds most likely died of delayed kinetics. 
Thus, in the present model, multiple parallel pathways were most likely 
induced and each specific pathway may have had multiple inducers. In 
addition, various stimuli may have activated certain pathways differently in 
different types of testicular cells.  
 
Due to the density of human testicular tissue, the presence of interstitial 
tissue with Leydig cells and their possible effects could not be ruled out, 
whereas in the similar rat model, interstitial tissue can be separated from 
the seminiferous tubules (152). For immunohistochemistry from cultured 
samples, we had to use small pieces of testicular tissue, which may have 
differed in size, rather than small segments of seminiferous tubules, 
leading to inhomogenous fixation. Human seminiferous tubules contain 
several spirally oriented stages of spermatogenesis, in which the number 
of apoptotic cells varies considerably. The length of the stage within the 
seminiferous tubule was not known and the representativeness of each 
stage remained unclear. Therefore, in our studies the quantification of 
immunohistochemical studies and ISEL analyses was difficult to conduct. 
The ISEL-positive cells in individual slides showed variation, which was 
independent of the treatments, especially in the squash preparations. 
 
The testis tissue samples were received from patients undergoing 
orchidectomy as a treatment for prostate cancer. Despite the advanced 
age of most of these patients, germ cells at all phases of maturation were 
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found during light microscopic and electron microscopic evaluation of the 
tissue. Samples from prepubertal boys or from younger men are scarce 
and were only available as small testicular biopsies taken for infertility or 
suspected disease, or as testis tissue removed for testicular cancer. These 
samples were therefore not suitable for our studies, since they were either 
too small or the tissue was disturbed by disease. Despite its limitations, 
this in vitro model maintained physiological contacts between the germ 
cells and the supporting Sertoli cells, thus enabling us to evaluate 
apoptotic mechanisms that involve interactions between different cell 
types within seminiferous tubules. Since the cellular responses have 
potential species specifity, results from animal studies may not apply to 
humans. With the aid of this model, we were able to examine the 
apoptotic mechanisms representative of the human testis.  
 
In vivo study 
 
Germ cell apoptosis in the rat testis, which resembles that of the mouse, is 
known to begin approximately 8 h after irradiation (146). The number of 
apoptotic cells increases until about 16 h, when mostly degenerating step 
1 spermatids and spermatogonia can be found. After 42 h, mainly 
meiotically dividing cells and early spermatids are undergoing apoptosis 
and after approximately 66 h the number of degenerating cells returns to 
control levels (146). Since physiological death of selected spermatocytes 
and spermatids is a common feature of normal spermatogenesis (136, 
187), a large number of physiologically apoptotic spermatocytes and 
spermatids is present in the testis. In the present in vivo study, the total 
amount of dying germ cells at the 16-h time point may have masked the 
protective effect of S1P on spermatogonia and thus interfered the 
interpretation of the results. A more detailed analysis of radiation-induced 
germ cell death in the mouse testis at several time points and a larger 
number of animals could have clarified the events occuring in the early 
phases of radiation-induced germ cell death. However, since stage-specific 
preparing of the squash preparations is time consuming, it is technically 
impossible (or at least extremely demanding) to make numerous samples 
from tubule segments in a short time period, which, however, is a 
prerequisite for maintenance of reliable incubation times.  
 
Generation of ceramide  
 
Ceramide can be formed at the initial step of the signaling pathway by 
enhanced de novo synthesis or by degradation of SM due to activation of 
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NSMase or ASMase (6). Whatever ceramide pathway is activated is highly 
dependent on the cell and stimulus. In our study, neither the ceramide 
synthetase inhibitor FB1, nor 2 different inhibitors of ASMase (desipramine 
and imipramine) significantly affected male germ cell apoptosis or 
testicular ceramide levels. More importantly, both ASMase inhibitors 
decreased the ASMase activity to the same level as was detected in 
nontreated controls. These results suggest that activation of the NSMase 
instead of ASMase contributes to the observed increase in ceramide levels 
during culture of the seminiferous tubules. Unfortunately, no specific 
NSMase inhibitors were available to further determine the role played by 
NSMase in the regulation of male germ cell apoptosis. The assumption of 
NSMase playing an important role in generation of ceramide, however, is 
supported by a number of observations showing a critical role for NSMase 
instead of ASMase in cell death (188-190). Somewhat surprisingly NAC, 
which effectively inhibits apoptosis (184), did not affect ceramide levels, 
although it is a glutathione precursor and glutathione is an inhibitor of 
NSMase (99, 189). This, however, may have been due to inability of the 
exogenous NAC to restore appropriate glutathione levels during in vitro 
culture conditions.  
 
ASMKO mice were recently found to have pathological testicular tissue and 
sperm due to lipid accumulation, although the germ cells appeared normal 
(175). Our studies on ASMKO mice (191) support the minor role of 
ASMase in the regulation of male germ cell apoptosis. We found ASMKO 
testes to contain significantly elevated levels of SM at the age of 8 wk. 
Concomitantly, the lipid vesicles resided in the Sertoli cells and in the 
interstitium, but not in the germ cells. When germ cell apoptosis was 
induced in vivo by irradiation, similar degrees of apoptosis were observed 
in the ASMKO and the WT testes (191). Similarly, under serum-free 
cultures both ASMKO and WT germ cells showed massive apoptosis after 
culture for up to 48 h and in both groups the ceramide levels became 
significantly elevated (191). Thus, ASMKO testes were able to produce 
ceramide, suggesting that apoptosis pathways other than ones dependent 
on ASMase, may be utilized for male germ cell apoptosis.  
 
Increased ceramide levels and exogenously added cell-permeable 
ceramide analogs were reported to affect mitochondrial functions (104, 
192). Therefore, to further study the intracellular target of ceramide in the 
apoptotic cascades, we tested the ability of KCN, a specific inhibitor of 
oxidative phosphorylation (complex IV) and a mitochondrial poison (193) 
to influence the testicular levels of ceramide. Although KCN inhibited germ 
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cell apoptosis effectively, it had no effect on the level of ceramide. This 
finding suggests that in human testicular germ cells, ceramide functions 
either upstream of or in parallel to mitochondrial complex IV and most 
likely upstream of ATP production, thus serving as an early intracellular 
effector of male germ cell apoptosis. 
 
S1P in inhibition of germ cell apoptosis of the human testis in 
vitro.  
 
S1P is an important regulator of stress-induced apoptosis (115), which 
acts as an intracellular signaling molecule or as a ligand to its cell-
membrane bound S1P1-5Rs (115). A central finding of the present thesis 
was that exogenous S1P, a plausible antagonist of ceramide, inhibited 
germ cell apoptosis of the human testis in vitro. In this culture model, we 
previously showed by electron microscopy, that the morphological signs of 
apoptosis is most often seen in spermatocytes and spermatids (161, 182-
185, 194). Whatever type of germ cell S1P is able to protect against 
apoptosis unfortunately was unclear and remains to be elucidated in 
future studies. 
 
Although several findings support the role of S1P as an antiapoptotic 
second messenger (119, 195), most tissues were recently shown to 
express one or more S1PR subtypes (196). The role played byS1P in the 
direct signaling or as a classic second messenger has thus become 
unclear, suggesting that highly cell-specific effects of S1P occur in the 
regulation of apoptosis (117, 197-199). We therefore wished to clarify the 
role of S1P in regulation of male germ cell death by evaluating the effect 
of dS1P (an S1P agonist that binds to S1PR but does not have the second 
messenger effect of intracellularly generated S1P) on this process. In 
contrast to S1P, dS1P did not inhibit male germ cell death, which suggests 
that the inhibitory effect of S1P on male germ cell death is a second 
messenger, receptor-independent effect. These findings may have been 
further elucidated with the aid of pertussis toxin or suramin, which are 
able to block the activity of S1PR at different levels. By adding S1P and 
one of these inhibitors simultaneously to the tissue culture, the second 
messenger effects of S1P could have been evaluated independently of 
S1PR. 
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Caspase 3  
 
Inhibition of apoptosis by S1P was related to caspase 3 in several cell lines 
(200-204). In our study, however, S1P suppressed the caspase 3 
activation only by 15% although it was able to inhibit apoptotic DNA 
laddering in testicular germ cells by 30%. This difference in degree of 
inhibition of caspase activation and DNA laddering by S1P may reflect the 
presence of parallel apoptotic pathways in the present model. Thus, 
simultaneous inductors other than serum deprivation may activate parallel 
apoptotic pathways some of which are not blocked by S1P. Finally, 
prolonged stress may lead to activation of secondary apoptotic pathways 
that lead to death of the S1P-treated cells with delayed kinetics. The 
regulation of caspase 3 by S1P may be regulated through sphingolipid 
metabolism (204) or through binding of S1P to S1PRs (202). In the human 
testis, caspase 3 activation may occur in the Sertoli cells and can be 
suppressed via the S1PR expressed in the Sertoli cells. This hypothesis is 
supported by the previous observation that although caspases play a 
central role in the apoptosis of human Sertoli cells, germ cell apoptosis 
appears to be caspase-independent (205). In our study model, however, 
apoptosis occurs mainly in the germ cells, whereas Sertoli cells are rather 
resistant to apoptosis (162, 184, 206). The role of caspase 3 in the Sertoli 
cells is therefore controversial. That apoptosis occurs mainly in the germ 
cells and caspase 3 is activated, although rather late, during induction of 
male germ cell apoptosis (I) suggests that caspase 3 activation may also 
occur in the germ cells.  
 
Since we observed no expression of S1PR in the germ cells, inhibition of 
germ cell apoptosis by S1P may be, at least partly, independent of 
caspase 3 inhibition. Caspase 3 activation may also occur only in the germ 
cells and not in the Sertoli cells, which is supported by the apoptosis-
resistant charasteristic of the Sertoli cells. S1P, via its receptors, may thus 
regulate the Sertoli cells, which paracrinically regulate caspase 3 activation 
in the germ cells. This regulation, however, would not be related to 
inhibition of male germ cell apoptosis, since dS1P does not inhibit male 
germ cell apoptosis. Indeed, although caspase 3 is the primary effector 
caspase in most apoptotic cascades, alternative caspase pathways, such 
as activation of caspase 7 or caspase 8 may be involved (64, 207). In 
certain stress or in vit o situations, the caspase 3 apoptosis cascade may 
be compensated for  by activation of other caspases; e.g. caspase 3-
deficient female germ cells are able to undergo apoptosisis possibly by 
compensatory induction of caspase 7 (207).  
r
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NF-κB and Akt  
 
NF-κB activates rapidly during the induction of human male germ cell 
apoptosis (83). In our study we found that S1P effectively inhibited NF-κB 
DNA-binding activity, whereas it only inhibited male germ cell apoptosis by 
28%. Our results are surprising, since in this culture model, the anti-
inflammatory drug sulfasalazine was recently found to block both 
apoptosis and NF-κB DNA-binding activity almost totally (83). It thus 
appears that NF-κB may not play a central role in inhibition of male germ 
cell apoptosis and that parallel apoptosis inhibitory pathways may exist. 
Secondly, S1P, together with NF-κB inhibition, may induce parallel 
proapoptotic pathways, possibly by binding to its receptors, since dS1P did 
not inhibit apoptosis or NF-κB activity.  
 
The best characterized IκB protein, IκBα, is degraded in the seminiferous 
tubules during germ cell death in the human testis (83). In the present 
study, inhibition of NF-κB DNA-binding activity by S1P was associated with 
inhibition of IκBα degradation, which suggests that S1P regulates NF-κB 
activity by inhibiting the degradation of IκB proteins. Since Akt may 
regulate NF-κB via the IKK-IκB regulatory cascade, we studied whether 
this cascade was involved in the S1P-induced inhibition of human male 
germ cell death. We found that S1P inhibited the phosphorylation of Akt 
and the degradation of IκBα concomitantly with inhibition of NF-κB 
activation and apoptosis. In contrast, dS1P did not have an inhibitory 
effect on these processes (Fig. 7). Our findings indicate that the regulation 
of apoptosis by S1P is unusual and involves a regulatory cascade 
consisting of various intracellular components. 
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Figure 7. Schematic illustration demonstating the hypothetical inhibitory pathway of S1P 
on germ cell apoptosis of the human testis.To inhibit male germ cell apoptosis, S1P 
suppresses activation of NF-κB upstream by inhibiting the phosphorylation of Akt and the 
degradation of IκBα. S1P is generated intracellularly by phosphorylation of sphingosine 
(which is degraded from ceramide by ceramidase) by the enzyme SPHK. Intracellularly 
generated S1P inhibits phosphorylation of Akt, which results in inhibition of IKK. IKK, in 
turn, regulates degradation of IκBα, which sequesters NF-κB in the cytosol. Since IκBα 
degradation is suppressed due to the inhibition of IKK, entry of NF-κB into the nucleus, 
and thus male germ cell apoptosis, is inhibited. S1PR appears to play no role in the 
inhibition of male germ cell death. 
 
AP-1  
 
In the present culture model, AP-1 activity began to increase in the 
testicular Sertoli cells earlier than the beginning of caspase 3 activation 
and apoptotic DNA fragmentation. AP-1, however, was activated later than 
NF-κB, which in this model activates strongly and rapidly in the Sertoli 
cells within 30 min (83). Considering the relatively slow initiation of AP-1 
activity as compared with the rapid activation of immediate mediators 
such as NF-κB, the role of AP-1 activation in germ cell apoptosis is not 
fully clear. Activation of AP-1 before caspase 3 and low-molecular-weight 
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DNA fragmentation suggest that AP-1 activation is associated with 
induction of apoptosis. Most likely, AP-1 is involved in apoptotic pathways 
that are induced in the present model after the initial rapid pathways. 
During severe stress, AP-1 in somatic Sertoli cells may thus induce 
transcription of Sertoli cell gene(s) that are able to mediate germ cell 
death. 
 
That S1P did not affect AP-1 activation, although it effectively inhibited 
NF-κB activation, suggests that AP-1 is not a universal regulator of human 
male germ cell apoptosis. Yet, AP-1 activation is not a secondary 
phenomenon, which always accompanies apoptosis, since concomitantly 
with inhibition apoptosis FSH was able to inhibit AP-1 activation. Thus, in 
the human testis many parallel apoptotic cascades may be present and 
the activation of AP-1 appears to be specifically regulated, depending on 
the stimulus.  
 
The finding that specific MAPK inhibitors, PD 98059 and SP 600125 did not 
affect apoptosis or AP-1 DNA-binding activity suggests that these 
inhibitors were not activated under the present culture conditions or that 
MAPK plays no role in the regulation of male germ cell death. The 
hypothesis that MAPK may play a minor role in the regulation of this 
apoptosis is supported by our finding in which ERK activation was 
increased in the cytosols of the Sertoli cells and the primary 
spermatocytes both in S1P- and dS1P-treated seminiferous tubules (II). 
More importantly, the expression was greater in the dS1P-treated than in 
the S1P-treated samples. Since dS1P does not appear to regulate male 
germ cell apoptosis, this finding suggests that the function(s) of ERK in 
the cultured testis are connected with the S1PRs. Thus, the regulatory 
function of ERK appears to be focused on events other than the regulation 
of male germ cell apoptosis. 
 
S1P and radiation-induced germ cell apoptosis in vivo 
 
The aim of the present study was to evaluate the potential ability of S1P in 
vivo to preserve male germ cells against irradiation-induced apoptosis. 
With flow cytometry and by back-calculation of spermatogenic stages, we 
indirectly showed that the number of apoptotic spermatogonia increases 
with increasing doses of radiation. The differentiating spermatogonia were 
the cell types most vulnerable to radiation-induced damage, since 21 d 
after irradiation, spermatocytes and spermatids representing the 4C 
population were decreased considerably, depending on the dose of 
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irradiation. S1P was able to modestly protect these early spermatogonia 
against 0.5 Gy radiation (observed as a normal 4C population that 
represented early spermatogonia at the time of irradiation). The finding 
suggests that apoptosis at these early developmental stages is more 
dependent on the SM pathway than apoptosis of germ cells in the later 
steps of spermatogenesis. Combining the therapeutics that preserve 
different stages of spermatogonia could be one possible methodfor to 
amplifying the effects of S1P on male germ cell preservation.  
 
By injecting S1P intratesticularly prior to irradiation, we aimed at delivering 
therapeutic concentrations of S1P at the site of testicular damage. Since 
metabolism and interactions of sphingolipid second messengers, as well as 
their ability to transit through membranes remains unknown, the 
intratesticular concentration of S1P may have been incorrect, and the 
effect of S1P therefore remained modest. The modest effect of S1P in vivo 
may also be explained by the hypothesis that the effect of intratesticular 
injection of S1P in vivo was mediated via S1PRs, which may activate 
regulatory pathways other than those related to the apoptosis machinery. 
We also recently demonstrated that after irradiation in vivo, the level of 
ceramide rises neither in ASMKO nor WT mice testes, although similar 
degrees of apoptosis are observed (191) .Since various stimuli appear to 
induce different apoptotic pathways, it is possible that the sphingolipid 
pathway does not play a universal role in radiation-induced apoptosis, 
although it is important in male germ cell death induced by serum 
deprivation in vitro (I).  
CONCLUSIONS AND FUTURE PROSPECTS 
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Conclusions and future prospects 
 
 
S1P is a sphingolipid, which effectively suppresses stress-induced 
apoptosis in several cell types and has a potential ability to inhibit 
germ cell loss caused by cancer treatments. The present series of 
studies aimed at elucidating the role played by S1P in inhibition of 
male germ cell death in vitro and in vivo. The main conclusions of 
this thesis are as follows: 
 
1. In a culture of human seminiferous tubules used as a model for 
stress situations, increase in intracellular ceramide appeared early 
in the apoptosis cascades supporting the concept that sphingolipids 
are early mediators of apoptosis and that ceramide plays a role in 
the induction of male germ cell death in vitro.  
 
2. S1P, a plausible antagonist of ceramide, was able to inhibit in 
vitro-induced male germ cell apoptosis of the human testis. 
 
3. Concomitantly with inhibition of apoptosis, S1P was able to 
inhibit the transcription factor NF-κB, which appears to be a crucial 
step in the induction of male germ cell apoptosis of the human 
testis.  
 
4. Although the expression of the S1P1R and S1P2R was detected in 
the somatic Sertoli cells of the human testis, only intracellularly 
generated S1P appears crucial in the regulation of male germ cell 
apoptosis, whereas S1PRs are not indispensable. 
 
5. In an animal model S1P, injected intratesticularly into the mouse 
testis prior to 0.5-Gy irradiation, was able to modestly inhibit 
radiation-induced apoptosis of the A-paired spermatogonia. The 
result suggests that apoptosis at the very early developmental 
stages of spermatogenesis may be more dependent on the SM 
pathway than apoptosis of germ cells at the later steps of 
spermatogenesis.  
 
Sphingolipid therapeutics hold great promise in different fields of 
cancer research (5). In basic science, characterization of the 
sphingolipid pathway, and elucidation of the dynamics between  
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sphingolipid metabolites therefore remain a promising field of 
investigation. Future challenges will include characterization of the 
specific roles of the various S1PRs as well as identification of the 
intracellular targets of S1P. The development of antagonists or 
agonists of S1PRs or of inhibitors or activators of enzymes that 
affect intracellular concentrations of S1P may enable amplification 
of S1P function in the human testis for therapeutic purposes. 
Alternatively, other as yet unknown compounds, possibly in the 
sphingolipid pathway, may prove to be more effective than S1P in 
protecting male germ cells against apoptosis caused by external 
stress.  
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